Post-election rally masks a sharp split in the AI trade. Who wins?
Wall Street rallied Wednesday after Democrats scored major victories in the midterm elections. But the broad rally hid…
Cramer: I asked tech insiders what to buy. They said Eli Lilly
Jim Cramer said Monday that even tech-focused people think the world of Eli Lilly stock, with one predicting…
More pain may be coming for the AI trade. Why I’m not giving up on it
You knew it had to happen. The charts foreordained it. I am talking about the collapse in every…
Jim Cramer says don’t chase the AI rebound just yet. Here’s what needs to happen first
CNBC’s Jim Cramer said he’s not in a hurry to rush back into artificial intelligence stocks, despite Monday’s…
Jim Cramer: Diversification matters in AI stock sell-off
Thursday’s sell-off in artificial intelligence stocks served as a reminder of why diversification is essential to staying invested…
Jim Cramer: SpaceX bull case is gaining credibility
CNBC’s Jim Cramer said Wednesday that rising borrowing costs are dividing the stock market into two camps: companies…
Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
OpenAI investors have approached the company about a new funding round
OpenAI investors have approached the company with proposals to kick-start a new funding round, but no formal discussions…
Meet Ottava, J&J’s surgical robot leading the healthcare giant into a lucrative new market
Johnson & Johnson is diving head-first into the deep end of the competitive robotic surgery market. The payoff…
Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks
On September 3, a caller asked whether to rotate out of artificial intelligence stocks and add to Eli…
Jim Cramer says investors are too focused on AI stocks. Here’s where he says to look instead
CNBC’s Jim Cramer said Tuesday that investors need to expand their horizons beyond the artificial intelligence trade. “There’s…
Jim Cramer Shares a Cautious Take on Oracle (ORCL) and Its Massive AI Buildout
On September 2, a caller pointed to market anxiety over Oracle Corporation’s (NYSE:ORCL) data center loans and asked…